In the News

/In the News

MVRF Supported Study At Penn Discovers Same Cell Death Pathway In 3 Forms Of Blindness

A study at Penn, supported by MVRF, discovered that the same cell death pathway is involved in 3 forms of blindness. This will take researchers one step closer to addressing multiple forms of disease with one treatment. Gene therapies developed by University of Pennsylvania School of Veterinary Medicine researchers have worked to correct different forms of blindness. While [...]

January 17th, 2014|

MVRF Launches 2013-14 SupportSight Seminars In Cleveland!

  Thank you, Cleveland!           On Tuesday, October 22, 2013 we hosted our first SupportSightSM Seminar of the 2013-2014 season in Cleveland, Ohio.  With 330 people in attendance, it was a huge success!  The seminar was an opportunity for patients, individuals, families and caregivers to learn about the latest advancements in [...]

December 2nd, 2013|

#GivingTuesday: Give The Gift Of Clear Vision

Dear MVRF Friends & Supporters, For #GivingTuesday, December 3, consider the best gift of all – finding a cure for retinal blindness. The Macula Vision Research Foundation (MVRF) is proud to be an official partner of #GivingTuesday, a national day of giving held on the Tuesday after Thanksgiving. Your #GivingTuesday gift: Will help save the sight of millions who are affected [...]

November 27th, 2013|

Penn Researchers Take First Step Toward A Macular Dystrophy Gene Therapy With Support From MVRF

  In a new study funded by the Macula Vision Research Foundation, University of Pennsylvania researchers report “encouraging” findings that mark the first clear step in developing a gene therapy that could prevent vision loss or even restore vision in individuals suffering from Best disease.  Click here to read the full press release from the University of [...]

October 16th, 2013|

MVRF Announces 2013 SupportSight℠ Seminar

  We are excited to announce our next SupportSight℠ Seminar in Cleveland, Ohio. When: Tuesday, October 22, 2013, 1-4pm. Where: The Mandel Jewish Community Center 26001 South Woodland Road Beachwood OH 44122 MVRF hosts SupportSight℠ Seminars in cities across the nation so that we can share the latest research findings and low vision techniques. At our seminars, [...]

September 4th, 2013|

Herb Lotman, Founder Of MVRF, Speaks To Morgan Stanley Wealth Management

Herb Lotman, founder of MVRF, spoke to a group of Morgan Stanley Wealth Management employees yesterday as part of their “Guest Lunch Speaker Series.” Herb championed our mission, explained how we operate and even had a few laughs! Here he is with Dan (pictured left) and Mark (pictured right). Thank you Morgan Stanley for allowing [...]

August 19th, 2013|

Japanese Research Team Begins World’s First Clinical Trial Of iPS Cells

Interesting article about groundbreaking research abroad! Researchers based in Japan started a pilot study that uses human induced pluripotent stem (iPS) cells to regenerate human retinas, the world's first clinical trial of iPS cells. Click here to read the full article!

August 8th, 2013|

Mario Tobia: A Champion Golfer

Next month, one of our dear MVRF friends, Mario Tobia, will be playing in the 2013 United States Blind Golf Association Open National Championship in Portland, Oregon. Mario received the 2013 Most Courageous Athlete of the Year Award from the Philadelphia Sports Writers Association and is currently the top ranked blind golfer going into the [...]

August 5th, 2013|

MVRF Supports Gene Therapy Study For Leber Congenital Amaurosis

Thanks to the results of a recent MVRF funded study conducted by a team of investigators led by Dr. Robert Molday at the University of British Columbia and Dr. William Hauswirth at the University of Florida, the field of retinal disease has become clearer. They have successfully restored visual function by delivering the normal RD3 [...]

July 3rd, 2013|

The Macula Vision Research Foundation (MVRF) Announces Their 2013-2014 Grant Recipients

MVRF awards $1.2 million to scientists in Italy, Netherlands and U.S. conducting groundbreaking research to find a cure for macular degeneration and other retinal diseases.  Click here to read the full press release.

June 24th, 2013|